Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 3/20 | 0.58 |
| ▸ | ACE | P12821 | 2/20 | 0.58 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.54 |
| ▸ | ECE1 | P42892 | 3/20 | 0.54 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.53 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.53 |
| ▸ | ITGAL | P20701 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30728822 | 0.96 | GHSR (0.61) | GHSRACEUTS2R | |
| SCHEMBL31593270 | 0.95 | GHSR (0.58) | GHSRACEUTS2R | |
| SCHEMBL30921655 | 0.94 | GHSR (0.60) | GHSRACEERAP2ECE1UTS2R | |
| SCHEMBL29924977 | 0.94 | GHSR (0.60) | GHSRACEERAP2ECE1 | |
| SCHEMBL31468798 | 0.94 | GHSR (0.60) | GHSRACEERAP2ECE1 | |
| SCHEMBL29925186 | 0.94 | GHSR (0.60) | GHSRACEERAP2ECE1 | |
| SCHEMBL29961801 | 0.92 | PRMT1 (0.58) | GHSRACEERAP2UTS2R | |
| SCHEMBL31742584 | 0.92 | PRMT1 (0.59) | GHSRACEERAP2UTS2R | |
| SCHEMBL29472045 | 0.91 | GHSR (0.64) | GHSRACEECE1 | |
| SCHEMBL29619357 | 0.91 | GHSR (0.64) | GHSRACEECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11628202-B2 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia | NYMOX CORPORATION (CA) | 2023-04-18 | — | — | US | disclosed |